The estimated overall survival for glioblastoma is 14.6 months overall [2]—1.1 years for IDH-1 wild type and 3.6 years for IDH-1 mutant subgroups [15], presently classified as grade 4 astrocytomas [1]. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).